NK1 receptor antagonist 2 can be used for the research of tinnitus and hearing loss[1].
[1]. Soren Rahn Christensen, et al. Composition comprising an nk-1 receptor antagonist and an ssri for the treatment of tinnitus and hearing loss. Patent. WO2008046882 A2
















